Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help ...

On Monday, Aclarion Inc (ACON) stock saw a decline, ending the day at $0.04 which represents a decrease of $-0.01 or -20.00% from the prior close of $0.05. The stock opened at $0.04 and touched a low ...

Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help ...

BROOMFIELD, CO - Aclarion, Inc. (NASDAQ:ACON, ACONW), a healthcare technology company with a current market capitalization of ...

In a stark reflection of investor sentiment, Aclarion Inc. (ACON) stock has plummeted to a 52-week low, trading at a mere ...

Comparatively, Aclarion has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Aclarion has a consensus price target of $1.30, indicating a potential upside of ...

ACON Stock Performance and Moving Averages. In recent trading, Aclarion Inc (ACON) stock price has shown some volatility, fluctuating 1.65% over the last five trades and -62.30% o ...

EQS-News: Aclarion, Inc. / Key word (s): Financial Aclarion Announces Closing of $14.4 Million Public Offering of Common Stock and Warrants 17.01.2025 / 22:50 CET/CEST The issuer is solely ...

BROOMFIELD, CO - January 17, 2025 (NEWMEDIAWIRE) - Aclarion, Inc. ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary ...

Aclarion, Inc. continues to demonstrate strong shareholder support for its corporate governance decisions and strategic direction, as evidenced by the positive outcomes of the Annual Meeting.